{"count": 3, "results": [{"_id": "34787028", "pmid": 34787028, "title": "Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance.", "journal": "Gynecol Endocrinol", "authors": ["Hernández-Jiménez JL", "Barrera D", "Espinoza-Simón E", "González J", "Ortíz-Hernández R", "Escobar L", "Echeverría O", "Torres-Ramírez N"], "date": "2022-01-01T00:00:00Z", "doi": "10.1080/09513590.2021.2003326", "meta_date_publication": "2022 Jan", "meta_volume": "38", "meta_issue": "1", "meta_pages": "2-9", "score": 50245.22, "text_hl": "Therefore, we propose that treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ could decrease @DISEASE_Hyperinsulinism @DISEASE_MESH:D006946 @@@HI@@@ and consequently @DISEASE_Hyperandrogenism @DISEASE_MESH:D017588 @@@HA@@@, restoring, at least in part, the @<m>DISEASE_Thyroid_Hormone_Metabolism_Abnormal</m> @DISEASE_MESH:C566454 @@@metabolic and hormonal disorders@@@ of @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@.", "citations": {"NLM": "Hernández-Jiménez JL, Barrera D, Espinoza-Simón E, González J, Ortíz-Hernández R, Escobar L, Echeverría O, Torres-Ramírez N. Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance. Gynecol Endocrinol. 2022 Jan;38(1):2-9. PMID: 34787028", "BibTeX": "@article{34787028, title={Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance.}, author={Hernández-Jiménez JL and Barrera D and Espinoza-Simón E and González J and Ortíz-Hernández R and Escobar L and Echeverría O and Torres-Ramírez N}, journal={Gynecol Endocrinol}, volume={38}, number={1}, pages={2-9}}"}}, {"_id": "21883348", "pmid": 21883348, "title": "Impaired gallbladder motility and the effect of metformin therapy in patients with polycystic ovary syndrome.", "journal": "Clin Endocrinol (Oxf)", "authors": ["Isik S", "Ozcan HN", "Ozuguz U", "Berker D", "Tutuncu Y", "Akbaba G", "Guler S"], "date": "2012-03-01T00:00:00Z", "doi": "10.1111/j.1365-2265.2011.04210.x", "meta_date_publication": "2012 Mar", "meta_volume": "76", "meta_issue": "3", "meta_pages": "373-8", "score": 50053.453, "text_hl": "A 12-week course of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy resulted in significant improvements in GB volume and GBEF values with a reversal of @<m>DISEASE_Thyroid_Hormone_Metabolism_Abnormal</m> @DISEASE_MESH:C566454 @@@metabolic and hormonal abnormalities@@@. ", "citations": {"NLM": "Isik S, Ozcan HN, Ozuguz U, Berker D, Tutuncu Y, Akbaba G, Guler S. Impaired gallbladder motility and the effect of metformin therapy in patients with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012 Mar;76(3):373-8. PMID: 21883348", "BibTeX": "@article{21883348, title={Impaired gallbladder motility and the effect of metformin therapy in patients with polycystic ovary syndrome.}, author={Isik S and Ozcan HN and Ozuguz U and Berker D and Tutuncu Y and Akbaba G and Guler S}, journal={Clin Endocrinol (Oxf)}, volume={76}, number={3}, pages={373-8}}"}}, {"_id": "18460557", "pmid": 18460557, "title": "Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome.", "journal": "J Clin Endocrinol Metab", "authors": ["Elkind-Hirsch K", "Marrioneaux O", "Bhushan M", "Vernor D", "Bhushan R"], "date": "2008-07-01T00:00:00Z", "doi": "10.1210/jc.2008-0115", "meta_date_publication": "2008 Jul", "meta_volume": "93", "meta_issue": "7", "meta_pages": "2670-8", "score": 50047.97, "text_hl": "Both @CHEMICAL_Exenatide @CHEMICAL_MESH:D000077270 @@@EX@@@ arms were more effective in promoting @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@ than @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ (P = 0.003). CONCLUSIONS: COM appears better than either @CHEMICAL_Exenatide @CHEMICAL_MESH:D000077270 @@@EX@@@ or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ alone on menstrual cycle frequency and @<m>DISEASE_Thyroid_Hormone_Metabolism_Abnormal</m> @DISEASE_MESH:C566454 @@@hormonal and metabolic derangements@@@. ", "citations": {"NLM": "Elkind-Hirsch K, Marrioneaux O, Bhushan M, Vernor D, Bhushan R. Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008 Jul;93(7):2670-8. PMID: 18460557", "BibTeX": "@article{18460557, title={Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome.}, author={Elkind-Hirsch K and Marrioneaux O and Bhushan M and Vernor D and Bhushan R}, journal={J Clin Endocrinol Metab}, volume={93}, number={7}, pages={2670-8}}"}}]}